Personalis, Inc. (PSNL)
6.625
-0.06
(-0.82%)
USD |
NASDAQ |
Apr 15, 16:00
6.625
0.00 (0.00%)
After-Hours: 20:00
Personalis Research and Development Expense (Annual) : 50.26M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Intellia Therapeutics, Inc. | 379.09M |
| Celldex Therapeutics, Inc. | 241.69M |
| Plus Therapeutics, Inc. | 8.379M |
| Atossa Therapeutics, Inc. | 21.18M |
| Abeona Therapeutics, Inc. | 24.26M |